Skip to main content
. 2020 Sep;26(9):10.18553/jmcp.2020.26.9.1153. doi: 10.18553/jmcp.2020.26.9.1153
≥ 5 Medications ≥ 10 Medications ≥ 15 Medications
OR (95% CI) OR (95% CI) OR (95% CI)
CP only vs. without CP
  Model 1 1.39 (1.30-1.49) 1.36 (1.26-1.47) 1.35 (1.23-1.49)
  Model 1 + race 1.38 (1.29-1.48) 1.35 (1.26-1.46) 1.35 (1.22-1.49)
CP + NDDs vs. without CP
  Model 1 2.52 (2.26-2.80) 2.23 (2.00-2.49) 1.59 (1.38-1.83)
  Model 1 + race 2.50 (2.24-2.78) 2.22 (1.99-2.48) 1.58 (1.38-1.82)
CP + NDDs vs. CP only
  Model 1 1.81 (1.60-2.06) 1.64 (1.43-1.87) 1.17 (0.99-1.39)
  Model 1 + race 1.81 (1.59-2.06) 1.64 (1.43-1.87) 1.17 (0.99-1.39)

Note: Model 1: age (as continuous), sex, U.S. region of residence, and multimorbidity.

a The without CP group served as the reference group.

CI = confidence interval; CP = cerebral palsy; NDD = neurodevelopmental disabilities; OR = odds ratio.